모든 사진(1)
크기 선택
보기 변경
5 MG
₩134,995
25 MG
₩521,203
About This Item
실험식(Hill 표기법):
C23H30FN3
CAS Number:
Molecular Weight:
367.50
MDL number:
UNSPSC 코드:
12352200
PubChem Substance ID:
NACRES:
NA.77
추천 제품
Quality Level
분석
≥98% (HPLC)
양식
powder
색상
white to off-white
solubility
DMSO: ≥10 mg/mL
주관자
Dainippon Sumitomo
저장 온도
room temp
SMILES string
CCN1CCN(CC1)c2cc(-c3ccc(F)cc3)c4CCCCCCc4n2
InChI
1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3
InChI key
XVGOZDAJGBALKS-UHFFFAOYSA-N
생화학적/생리학적 작용
Blonanserin is a D2/5-HT2 receptor antagonist; atypical antipsychotic.
특징 및 장점
This compound was developed by Dainippon Sumitomo. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
신호어
Warning
유해 및 위험 성명서
예방조치 성명서
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 4
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
가장 최신 버전 중 하나를 선택하세요:
시험 성적서(COA)
Lot/Batch Number
Ming Peng et al.
Journal of chromatographic science, 50(8), 727-732 (2012-05-19)
Blonanserin is a novel atypical antipsychotic agent for the treatment of schizophrenia. Ethyl alcohol, isopropyl alcohol and toluene are utilized in the synthesis route of this bulk drug. A new validated gas chromatographic (GC) method for the simultaneous determination of
Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference.
Yutaro Suzuki et al.
Psychiatry and clinical neurosciences, 66(6), 534-535 (2012-10-17)
Three cases of schizophrenia showing improvement after switching to blonanserin.
Naohiro Kurotaki et al.
Psychiatry and clinical neurosciences, 65(4), 396-397 (2011-06-21)
Koji Kato et al.
Psychiatry and clinical neurosciences, 65(4), 389-391 (2011-05-17)
The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were
Tomomi Tenjin et al.
Human psychopharmacology, 27(1), 90-100 (2012-01-27)
The purpose of this study was to evaluate the effects of blonanserin, a novel antipsychotic, on cognitive function in first-episode schizophrenia. Twenty-four antipsychotic-naïve patients with first-episode schizophrenia participated in the study. Blonanserin was given in an open-label design for 8 weeks.
문서
We offer many products related to serotonin receptors for your research needs.
활성 필터
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.
